Prognostic implications of microcirculatory perfusion versus macrocirculatory perfusion in cardiogenic shock: a CULPRIT-SHOCK substudy.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 14 9 2019
medline: 28 11 2020
entrez: 14 9 2019
Statut: ppublish

Résumé

After early revascularisation, restoration of macrocirculatory perfusion parameters is the primary objective in the management of cardiogenic shock complicated acute myocardial infarction. Nevertheless, vital organ perfusion may be compromised at the systemic microcirculatory level, even in patients with preserved macrohaemodynamics. Microvascular perfusion was shown to have independent prognostic value for early mortality. The present study aims to compare the prognostic value of microcirculatory versus macrocirculatory perfusion parameters. This substudy of the culprit lesion-only percutaneous coronary intervention versus multivessel percutaneous coronary intervention in cardiogenic shock (CULPRIT-SHOCK) trial examined the sublingual capillary network using videomicroscopy post-percutaneous coronary intervention to determine the proportion of perfused capillaries (<20 µm) and perfused capillary density. Thirty-day follow-up was performed to obtain the occurrence of a combined clinical endpoint of all-cause death and renal replacement therapy. Videomicroscopy measurements were performed in 66 patients. There was a significant adjusted association between microcirculatory perfusion parameters and the combined clinical endpoint (proportion of perfused capillaries: There is a significant and independent association between microcirculatory perfusion parameters perfused capillary density and proportion of perfused capillaries and the combined clinical endpoint of all-cause death and renal replacement therapy at 30 days follow-up. In patients with loss of haemodynamic coherence between microcirculatory and macrocirculatory perfusion parameters, microcirculatory perfusion parameters confer dominant prognostic value.

Sections du résumé

BACKGROUND BACKGROUND
After early revascularisation, restoration of macrocirculatory perfusion parameters is the primary objective in the management of cardiogenic shock complicated acute myocardial infarction. Nevertheless, vital organ perfusion may be compromised at the systemic microcirculatory level, even in patients with preserved macrohaemodynamics. Microvascular perfusion was shown to have independent prognostic value for early mortality. The present study aims to compare the prognostic value of microcirculatory versus macrocirculatory perfusion parameters.
METHODS METHODS
This substudy of the culprit lesion-only percutaneous coronary intervention versus multivessel percutaneous coronary intervention in cardiogenic shock (CULPRIT-SHOCK) trial examined the sublingual capillary network using videomicroscopy post-percutaneous coronary intervention to determine the proportion of perfused capillaries (<20 µm) and perfused capillary density. Thirty-day follow-up was performed to obtain the occurrence of a combined clinical endpoint of all-cause death and renal replacement therapy.
RESULTS RESULTS
Videomicroscopy measurements were performed in 66 patients. There was a significant adjusted association between microcirculatory perfusion parameters and the combined clinical endpoint (proportion of perfused capillaries:
CONCLUSIONS CONCLUSIONS
There is a significant and independent association between microcirculatory perfusion parameters perfused capillary density and proportion of perfused capillaries and the combined clinical endpoint of all-cause death and renal replacement therapy at 30 days follow-up. In patients with loss of haemodynamic coherence between microcirculatory and macrocirculatory perfusion parameters, microcirculatory perfusion parameters confer dominant prognostic value.

Identifiants

pubmed: 31517505
doi: 10.1177/2048872619870035
doi:

Types de publication

Clinical Trial Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-119

Auteurs

Gilbert Wm Wijntjens (GW)

Heart Center, Amsterdam Universitair Medische Centra, The Netherlands.

Karl Fengler (K)

Department of Internal Medicine/Cardiology, University Hospital, Germany.

Georg Fuernau (G)

Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University of Luebeck, Germany.

Christian Jung (C)

Medical Faculty, University Hospital Düsseldorf, Germany.

Corstiaan den Uil (C)

Department of Intensive Care Medicine, Erasmus University Medical Center, The Netherlands.
Department of Cardiology, Erasmus University Medical Center, The Netherlands.

Sakir Akin (S)

Department of Cardiology, Erasmus University Medical Center, The Netherlands.
Department of Intensive Care, Haga Teaching Hospital, The Hague, The Netherlands.

Tim P van de Hoef (TP)

Heart Center, Amsterdam Universitair Medische Centra, The Netherlands.

Rokas Šerpytis (R)

Clinic of Cardiac and Vascular Diseases, Vilnius University, Lithuania.

Roberto Diletti (R)

Department of Cardiology, Erasmus University Medical Center, The Netherlands.

José Ps Henriques (JP)

Heart Center, Amsterdam Universitair Medische Centra, The Netherlands.

Pranas Šerpytis (P)

Clinic of Cardiac and Vascular Diseases, Vilnius University, Lithuania.

Holger Thiele (H)

Department of Internal Medicine/Cardiology, University Hospital, Germany.

Jan J Piek (JJ)

Heart Center, Amsterdam Universitair Medische Centra, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH